Reaction profile

The FDA adverse-event record for nasal ulceration

Name: Nasal ulceration - FDA Animal Adverse Reaction
Creator: PlainBreed
License: https://open.fda.gov/license/

12 FDA reports name nasal ulceration, a lower-volume reaction in the CVM extract (VeDDRA 2985). Plate stamps and neighbourhood peers follow.

#2390 of 2,481
by report volume (all reactions): 12
reports citing this reaction: 8.3%
death-coded share: Dog
most-affected species

Compiled by PlainBreed

Verify with FDA CVM →

FDA AER · VeDDRA plate

Code 2985 VOL-TRACE

VOL-TRACE · DEATH-PAR · BOTTOM-DECILE · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

VOL-TRACE 12 reports
DEATH-PAR 8.3%
BOTTOM-DECILE #2390/2481
PHOTO-FINISH Agitated state of mind
SPECIES-DOG Dog · 12
DRUG-LEAD Oclacitinib Malea… · 5
DESK-WIDE 10 breeds
BOOK-FULL 8/8 fields

Nearest volume peer: Agitated state of mind (±0 reports)

Instrument codes from this reaction’s FDA CVM adverse-event extract: volume band, death-coded share, corpus rank, photo-finish peer, lead species, lead drug, breed desk, and book completeness. Not a clinical diagnosis.

Lower-volume neighbourhood around Nasal ulceration

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

FDA AER report volume · neighbourhood around Nasal ulceration

What the FDA AER plate says about Nasal ulceration

Signature read: 12 reports place Nasal ulceration in the lower third of FDA AER volume (#2390 of 2,481). Report volume is lower-third scale: 12 named reports in the openFDA extract. 1 of 12 reports were death-coded (8.3% of named reports, not a population mortality rate). Nearest volume peer: Agitated state of mind (±0 reports). Lead species Dog (12). Lead co-reported drug Oclacitinib Maleate (5).

Read these counts as reporting volume, not risk: per our methodology, Lead co-reported drug Oclacitinib Maleate appears in filings alongside this reaction; that is association, not causation. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 12

Breeds Most Affected

Shepherd Dog - German 2

Retriever - Golden 2

Collie - Rough-haired 1

Weimaraner 1

Shepherd Dog - Australian 1

Pointing Dog - Hungarian Short-haired (Vizsla) 1

Retriever - Labrador 1

Retriever - Flat-coated 1

Pinscher - Miniature 1

Bulldog - English 1

Associated Drugs

Oclacitinib Maleate 5

Bedinvetmab 5

Prednisone 4

Tigilanol Tiglate 2

Diphenhydramine 2

Famotidine 2

Carprofen 2

Butorphanol Tartrate 1

Acepromazine 1

Levetiractam 1

Gabapentin 1

Keppra 1

Cefpodoxime 1

Animax 1

Zymox Otic 1

Moxidectin 1

Gucosamine, Glyconade 1

Probiotic 1

Vitamin E 1

Fish Oil 1

What to do with this reaction

Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
Browse the full reaction directory to compare report counts across reaction types. All reactions

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Nasal ulceration (#2390 of 2,481 by report volume); death-coded 8.3%. PlainBreed reaction plate · report volume stamp 12 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →